Tasuku Nakabori
Overview
Explore the profile of Tasuku Nakabori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urabe M, Ikezawa K, Seiki Y, Watsuji K, Kawamoto Y, Hirao T, et al.
DEN Open
. 2025 Jan;
5(1):e70048.
PMID: 39741901
Objectives: Endoscopic ultrasonography (EUS) plays an important role in the diagnosis of pancreatobiliary diseases. However, an appropriate sedation method for EUS has not been established. Therefore, this study aimed to...
2.
Ohkawa K, Nakabori T, Mukai K, Kozumi K, Urabe M, Kai Y, et al.
PLoS One
. 2024 Oct;
19(10):e0311930.
PMID: 39446769
Treatment strategies for preventing liver fibrosis have not yet been established. Letrozole, widely used for breast cancer, has recently been reported to suppress liver fibrosis in murine models. Therefore, we...
3.
Urabe M, Ikezawa K, Seiki Y, Watsuji K, Kawamoto Y, Hirao T, et al.
Sci Rep
. 2024 Sep;
14(1):21953.
PMID: 39304727
Antiapoptotic protein, including Mcl-1, expression is frequently observed in pancreatic cancer. Gemcitabine plus nabpaclitaxel (GnP) is the standard chemotherapy for metastatic pancreatic cancer (MPC); however, predictive markers for its efficacy...
4.
Nakabori T, Ikawa T, Kozumi K, Urabe M, Kai Y, Takada R, et al.
Clin J Gastroenterol
. 2024 Aug;
17(6):1053-1057.
PMID: 39141191
Combining bevacizumab with atezolizumab enhances the antitumor effects of the treatment by activating an immune response. This combination is approved for the treatment of unresectable hepatocellular carcinoma (HCC). An abscopal...
5.
Kawamoto Y, Yamai T, Ikezawa K, Seiki Y, Watsuji K, Hirao T, et al.
BMC Cancer
. 2024 Aug;
24(1):1000.
PMID: 39134950
Background: Germline breast cancer susceptibility gene (gBRCA) mutation in patients with pancreatic cancer (PC) is not common in clinical practice. Therefore, factors that efficiently show gBRCA mutations and the real-world...
6.
Nakabori T, Abe Y, Honma K, Ohkawa K
Gastro Hep Adv
. 2024 Aug;
1(1):1-3.
PMID: 39129934
Liver metastasis is not uncommon in various malignant tumors. Most of liver metastases present as discrete masses. However, liver metastases can appear as diffuse infiltrating neoplasms. Infiltration of malignant cells...
7.
Nakabori T, Kunimasa K, Kawabata M, Higashi S, Mukai K, Kawamura T, et al.
Cancer Med
. 2024 Jun;
13(12):e7430.
PMID: 38924675
Aim: Atezolizumab and bevacizumab (Atezo/Bev) combination immunotherapy regimens and direct oral anticoagulants (DOACs) are both associated with bleeding. Therefore, combining Atezo/Bev regimens with DOACs may exacerbate the bleeding risk. This...
8.
Urabe M, Ikezawa K, Kozumi K, Kai Y, Takada R, Mukai K, et al.
Clin J Gastroenterol
. 2024 May;
17(4):771-775.
PMID: 38743170
Pancreatic acinar cell carcinoma (PACC) is a rare cancer with no specific treatment. The treatment and chemotherapy for PACC are selected according to pancreatic ductal adenocarcinoma (PDAC). Herein, we describe...
9.
Seiki Y, Ikezawa K, Watsuji K, Urabe M, Kai Y, Takada R, et al.
Int J Clin Oncol
. 2024 May;
29(8):1173-1181.
PMID: 38724773
Background: Although patients with advanced pancreatic cancer (PC) often experience dysgeusia with zinc deficiency during chemotherapy, data on zinc supplementation for dysgeusia and its effects on nutritional status are scarce....
10.
Yamai T, Ikezawa K, Seiki Y, Watsuji K, Kawamoto Y, Hirao T, et al.
Cancer Med
. 2024 May;
13(9):e7189.
PMID: 38706442
Objectives: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is used for pathological diagnosis and obtaining samples for molecular testing, facilitating the initiation of targeted therapies in patients with pancreatic cancer. However, samples...